Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, PR China.
PLoS One. 2013 Apr 25;8(4):e62571. doi: 10.1371/journal.pone.0062571. Print 2013.
Frequent deletions of the kinesin-like protein gene 1B (KIF1B) have been reported in neural tumors. Recently, a genome-wide association study revealed an association between polymorphisms in the KIF1B gene and the risk of hepatocellular carcinoma (HCC), and several case-control studies have further investigated this relationship. However, these studies have yielded controversial results. We therefore performed a meta-analysis to derive a more precise estimation of the association between the KIF1B gene polymorphisms and HCC risk.
METHODOLOGY/PRINCIPAL FINDING: PubMed, EMBASE, the ISI Web of Science and the CNKI databases were systematically searched to identify relevant studies. A total of 5 studies containing 13 cohorts with 5,773 cases and 6,404 controls were included. Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the associations. Subgroup analyses were conducted based on ethnicities, sample sizes and quality scores. Overall, the G allele at rs17401966 of the KIF1B gene was associated with a significantly decreased risk for HCC (OR = 0.81, 95%CI: 0.70-0.93; P = 0.003). Furthermore, subgroup analyses showed that the G allele at rs17401966 of the KIF1B gene significantly reduced the risk for HCC in Chinese cohorts (OR = 0.76, 95%CI: 0.64-0.90; P = 0.002), large-sample-size cohorts (OR = 0.80, 95%CI: 0.73-0.88, P<0.01) and high-quality cohorts (OR = 0.78, 95%CI: 0.71-0.87, P<0.01). However, no significant associations were found in small-sample-size cohorts, studies with low-quality scores and when excluding the cohorts from the study reporting the original discovery.
CONCLUSION/SIGNIFICANCE: These findings demonstrate that the presence of the G allele at rs17401966 of the KIF1B gene may decrease the risk for HCC and suggest that KIF1B may play a critical role in the development of HCC. High-quality studies with larger sample sizes and different ethnic populations will be of great value to further confirm these findings.
在神经肿瘤中,已报道有频繁的驱动蛋白样蛋白 1B(KIF1B)基因缺失。最近,一项全基因组关联研究揭示了 KIF1B 基因多态性与肝细胞癌(HCC)风险之间的关联,并且有几项病例对照研究进一步调查了这种关系。然而,这些研究的结果存在争议。因此,我们进行了荟萃分析,以更准确地评估 KIF1B 基因多态性与 HCC 风险之间的关联。
方法/主要发现:系统地检索了 PubMed、EMBASE、ISI Web of Science 和中国知网(CNKI)数据库,以确定相关研究。共纳入了 5 项研究,包含 13 个队列,共 5773 例病例和 6404 例对照。使用比值比(ORs)及其 95%置信区间(CIs)来评估关联的强度。根据种族、样本量和质量评分进行了亚组分析。总体而言,KIF1B 基因 rs17401966 处的 G 等位基因与 HCC 风险显著降低相关(OR = 0.81,95%CI:0.70-0.93;P = 0.003)。此外,亚组分析显示,KIF1B 基因 rs17401966 处的 G 等位基因在中国人群中显著降低了 HCC 的风险(OR = 0.76,95%CI:0.64-0.90;P = 0.002),在大样本量队列中(OR = 0.80,95%CI:0.73-0.88,P<0.01)和高质量队列中(OR = 0.78,95%CI:0.71-0.87,P<0.01)。然而,在小样本量队列、低质量评分的研究以及排除了原始发现研究的队列中,没有发现显著的关联。
结论/意义:这些发现表明,KIF1B 基因 rs17401966 处的 G 等位基因的存在可能降低 HCC 的风险,并提示 KIF1B 可能在 HCC 的发生发展中发挥关键作用。具有更大样本量和不同种族人群的高质量研究将非常有助于进一步证实这些发现。